in this issue
Regions :: North America :: U.S.
BioAmber closes $25-million debt financing
11:19 AM MDT | July 18, 2013 | Rebecca Coons
BioAmber (Minneapolis) announced today that it has closed a $25-million, three-year term loan with Hercules Capital. The financing helps ensure that the company has the capital needed to complete construction and start-up of its 30,000-m.t./year biobased succinic acid facility at Sarnia, ON. The debt facility is in addition to the $71.9 million of net proceeds that BioAmber received in connection with its initial public offering in May. The company had originally filed for an IPO worth up to $150...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee